The Hope of the Future in Myeloma Treatment with Dr. Sikander Ailawadhi
The Hope of the Future in Myeloma Treatment with Dr. Sikander Ailawadhi image
Aug 23, 2022 / 06:30PM - 08:00PM EDT
Florida Myeloma Community Chapter
videocam
Can't make it to the event?
We send a recording to all registered participants of the event!

Event Description

The Florida Myeloma Community Chapter meets to discuss the hope for the future lives of patients and families affected by myeloma thanks to new and developing therapies. Dr. Ailawadhi is excited to hear patient and caregiver thoughts, questions and feelings on this subject. Do you have hope? What questions and concerns do you have about the future? We look forward to a great discussion together. 

Schedule & Agenda

The panelist Audrey Burton-Bethke
Introduction
06:30PM
Audrey Burton-Bethke
Audrey introduces the agenda of the event and featured speaker Dr. Sikander Ailawadhi
The panelist Dr. Sikander Ailawadhi
Presentation
06:35PM
Dr. Sikander Ailawadhi
Dr. Ailawadhi discusses the hope for the future lives of patients and families affected by myeloma thanks to new and developing therapies.
The panelist Audience
Questions and Answers
07:15PM
Audience
Type your questions in the chat and we will answer them!

Speakers & Moderators

The panelist Audrey Burton-Bethke
Audrey Burton-Bethke

Audrey joined the HealthTree Foundation as the Myeloma Community Program Director in 2020. While not knowing much about myeloma at the start, she has since worked hard to educate herself, empathize and learn from others' experiences. She loves this job. Audrey is passionate about serving others, loves learning, and enjoys a nice mug of hot chocolate no matter the weather.

Read Bio
The panelist Dr. Sikander Ailawadhi
Dr. Sikander Ailawadhi

Sikander Ailawadhi, MD, is a Professor of Medicine in the Division of Hematology/Oncology at the Mayo Clinic Florida located in Jacksonville, Florida. He is also the Lead for the International Cancer Center. Dr Ailawadhi's career focus includes the treatment of plasma cell disorders, multiple myeloma (MM), Waldenström's macroglobulinemia, and chronic lymphocytic leukemia (CLL). His research focuses on understanding the epidemiology and pathophysiology of these disorders; evaluating the benefit of various therapeutic strategies in different populations based on racial-ethnic and socioeconomic diversity; and developing novel therapeutics by means of conducting several regional and national clinical trials, such as clinical trials for novel drugs. Dr Ailawadhi has a special interest in understanding the disparities in care of cancer patients and their outcomes with a special focus on patients from different racial and ethnic backgrounds.

Read Bio

Have Any Questions?

Thank you for your interest in the event. If you have any questions, we would love to help!

Feel free to give us a call or send us a message below.

support

Get In Touch With Us

phone

+1 800 709 1113

email

Support@healthtree.org

Get the latest thought leadership on Myeloma delivered straight to your inbox.

Subscribe to the weekly "HealthTree Community for Myeloma Newsletter" for Myeloma news, life with Myeloma stories, Myeloma clinical trials, Myeloma 101 articles and events with Myeloma experts.

Thanks to our HealthTree Community for Myeloma Sponsors:

Legend Biotechnologies
Bristol Myers Squibb
Abbvie
Genentech
GSK
Janssen Oncology

Follow Us

facebook instagram twitter youtube

Copyright © 2022 HealthTree Foundation. All Rights Reserved.

The HealthTree Foundation for Multiple Myeloma (formerly know as Myeloma Crowd) is a qualified 501(c)(3) tax-exempt organization. Tax ID 45-5354811

 https://www.guidestar.org/profile/45-5354811